The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis

Renal anemia in chronic kidney disease (CKD) is associated with poor outcomes. Hypoxia-inducible factor (HIF) stabilizer, which induces endogenous erythropoietin synthesis and enhances iron mobilization, is a novel treatment for anemia in CKD. We conducted a systematic review and meta-analysis to an...

Descripción completa

Detalles Bibliográficos
Autores principales: Takkavatakarn, Kullaya, Thammathiwat, Theerachai, Phannajit, Jeerath, Katavetin, Pisut, Praditpornsilpa, Kearkiat, Eiam-Ong, Somchai, Susantitaphong, Paweena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157772/
https://www.ncbi.nlm.nih.gov/pubmed/37151413
http://dx.doi.org/10.1093/ckj/sfac271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157772/
https://www.ncbi.nlm.nih.gov/pubmed/37151413
http://dx.doi.org/10.1093/ckj/sfac271

Ejemplares similares